These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28007087)

  • 1. The year in review: The best of 2016 in the Annals.
    Marshall GD; Bielory L; Walter Canonica G; Desai M; Ellis AK; Hsieh FH; Grayson MH; Greenhawt M; Lieberman JA; Montanaro A; Oppenheimer J
    Ann Allergy Asthma Immunol; 2017 Jan; 118(1):4-9. PubMed ID: 28007087
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments allergy in 2019 through the eyes of Clinical and Experimental Allergy, Part II clinical allergy.
    Roberts G; Almqvist C; Boyle R; Crane J; Hogan SP; Marsland B; Saglani S; Woodfolk JA
    Clin Exp Allergy; 2020 Dec; 50(12):1302-1312. PubMed ID: 33283366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in aeroallergen immunotherapy.
    Chan SK
    Curr Opin Pediatr; 2019 Dec; 31(6):828-834. PubMed ID: 31693594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue loss with subcutaneous immunotherapy--Nicolau syndrome.
    Tierce ML; Schultz SM; Lanier BQ
    J Allergy Clin Immunol Pract; 2016; 4(1):154-5. PubMed ID: 26362220
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on house dust mite immunotherapy: are more studies needed?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):542-8. PubMed ID: 25115684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in Allergic Asthma - 5 year analysis: Is it a curative approach?
    Coutinho Costa J; Machado JN; Ferreira C; Gama JMR; Almeida T; Arrobas AM
    Pulmonology; 2019; 25(3):183-185. PubMed ID: 30862426
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life, when to step down asthma therapy and remembering allergic rhinitis.
    Roberts G
    Clin Exp Allergy; 2017 Apr; 47(4):440-441. PubMed ID: 28370598
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma.
    Lambert N; Guiddir T; Amat F; Just J
    Pediatr Allergy Immunol; 2014 Dec; 25(8):829-32. PubMed ID: 25387446
    [No Abstract]   [Full Text] [Related]  

  • 11. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A web-based tool for improving adherence to sublingual immunotherapy.
    Tripodi S; Comberiati P; Di Rienzo Businco A
    Pediatr Allergy Immunol; 2014 Oct; 25(6):611-2. PubMed ID: 24965104
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of tonsillectomy on the efficacy of house dust mite sublingual immunotherapy.
    Refaat M; Ashour ZA; Farres MN; Eissa AM; Elsayed MM
    Allergol Immunopathol (Madr); 2015; 43(1):108-11. PubMed ID: 24388811
    [No Abstract]   [Full Text] [Related]  

  • 14. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory Role of HLA-G in Allergic Diseases.
    Murdaca G; Contini P; Negrini S; Ciprandi G; Puppo F
    J Immunol Res; 2016; 2016():6865758. PubMed ID: 27413762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THE OFFICIAL HAND BOOK FOR ALLERGEN IMMUNOTHERAPY IN MITE-ALLERGY - CAUSAL TREATMENT FOR PERENNIAL ALLERGIC AIRWAY DISEASES].
    Nagata M
    Arerugi; 2016 Jul; 65(7):908-12. PubMed ID: 27545055
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
    Spertini F; Perrin Y; Audran R; Pellaton C; Boudousquié C; Barbier N; Thierry AC; Charlon V; Reymond C
    J Allergy Clin Immunol; 2014 Jul; 134(1):239-240.e13. PubMed ID: 24797422
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy in allergic rhinitis and lower airway outcomes.
    Cardona V; Luengo O; Labrador-Horrillo M
    Allergy; 2017 Jan; 72(1):35-42. PubMed ID: 27439141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-depot house-dust mite allergen extract for Chinese with allergic rhinitis and asthma.
    Li X; Wang X; Lin X; Xu G; Tao Z; Jiang W; Cheng L; Guo Y; Lai H; Shen K
    Am J Rhinol Allergy; 2016 May; 30(3):201-8. PubMed ID: 27216351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy: an option in the management of occupational asthma?
    Sastre J; Quirce S
    Curr Opin Allergy Clin Immunol; 2006 Apr; 6(2):96-100. PubMed ID: 16520672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.